CXCR4 and medulloblastoma: We showed a requirement for CXCR4 signaling in medulloblastoma xenografts using a clinically approved inhibitor, AMD3100 (Plerixafor/Mozobil®, Genzyme) which blocked in vivo growth of tumors [64].